[HTML][HTML] Narrow therapeutic index drugs: a clinical pharmacological consideration to flecainide

J Tamargo, JY Le Heuzey, P Mabo - European journal of clinical …, 2015 - Springer
Purpose The therapeutic index (TI) is the range of doses at which a medication is effective
without unacceptable adverse events. Drugs with a narrow TI (NTIDs) have a narrow …

[图书][B] Delirium: acute confusional states in palliative medicine

A Caraceni, L Grassi - 2011 - books.google.com
Delirium is a complex syndrome with a multifactorial aetiology and is characterized by
marked disturbances of consciousness, attention, memory, perception, thought, sleep-wake …

[HTML][HTML] Drug-associated delirium in cancer patients

A Caraceni - EJC Supplements, 2013 - ncbi.nlm.nih.gov
Delirium is a disorder of consciousness and attention; it is one of the most common
neurological complications seen in general in the medically ill hospitalised patient, and is …

[HTML][HTML] Case Files from the University of California San Diego Medical Toxicology Fellowship: Neonatal Flecainide Toxicity from an Accidental Dosing Error

J Seltzer, A Schneir - Journal of Medical Toxicology, 2024 - Springer
Four days following discharge, the patient's mother recognized that the provided flecainide
had a concentration (20 mg/mL) twice of that intended (10 mg/mL). The patient had received …

Guanfu base A, an antiarrhythmic alkaloid of Aconitum coreanum, is a CYP2D6 inhibitor of human, monkey, and dog isoforms

J Sun, Y Peng, H Wu, X Zhang, Y Zhong, Y Xiao… - Drug Metabolism and …, 2015 - ASPET
Guanfu base A (GFA) is a novel heterocyclic antiarrhythmic drug isolated from Aconitum
coreanum (Lèvl.) rapaics and is currently in a phase IV clinical trial in China. However, no …

Validation of interaction databases in psychopharmacotherapy

M Hahn, SC Roll - Der Nervenarzt, 2018 - Springer
Hintergrund Interaktionsdatenbanken sind durch zunehmende Polypharmazie ein immer
wichtigeres Tool zur Erhöhung der Arzneimitteltherapiesicherheit. Es stehen mehrere …

Challenges in therapeutic drug monitoring of digoxin and other antiarrhythmic drugs

A Dasgupta - Therapeutic Drug Monitoring, 2024 - Elsevier
Digoxin due to its narrow therapeutic range is a challenge for therapeutic drug monitoring
because digoxin immunoassays are affected by a variety of drugs and herbal supplements …

Positive inotropic drugs and drugs used in dysrhythmias

A Finzi - Side Effects of Drugs Annual, 2012 - Elsevier
This review of the 2010 publications on positive inotropic drugs and drugs used in
dysrhythmias covers cardiac glycosides, herbal glycosides, and other positive inotropic …

[PDF][PDF] Untersuchungen zur Pharmakokinetik und zum Interaktionspotential des Antiarrhythmikums Flecainid

P Zimmermann - 2015 - db-thueringen.de
2 eines Enzyms zu bestimmen, ist die Phänotypisierung der Genotypisierung vorzuziehen.
Es zeigte sich, dass genotypisch als hetEM charakterisierte Probanden phänotypisch …

17 Positive drugs used inotropic in dysrhythmias drugs and

A Finzi - Side Effects of Drugs Annual: A worldwide yearly …, 2012 - books.google.com
Observational studies In elderly Spanish patients (mean age 82 years, 84% women) studied
during January to September 2008, digitalis intoxication was confirmed in 42 cases by …